Activest Wealth Management
RVMD icon

Activest Wealth Management’s Revolution Medicines RVMD Stock Holding History

Activest Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.98K Buy
34
+28
+467% +$5.55K ﹤0.01% 651
2026
Q2 		$1.12K Buy
+6
New +$876 ﹤0.01% 938
2025
Q4 		– Sell
-1
Closed -$47 – 1280
2025
Q3 		$47 Buy
+1
New +$39 ﹤0.01% 1087

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Activest Wealth Management's RVMD Position: Q3 2026 in Review

Activest Wealth Management increased its Revolution Medicines (RVMD) stake by 467% in Q3 2026, buying an estimated $5.55K and bringing the position to 34 shares worth $6.98K. The position accounts for ﹤0.01% of the portfolio, ranked #651.

Activest Wealth Management first reported a position in RVMD in Q3 2025 and has held it in 3 quarters since. 373 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Activest Wealth Management held 34 shares of Revolution Medicines worth $6.98K as of Q3 2026.
  • Activest Wealth Management bought 28 Revolution Medicines shares in Q3 2026, an estimated $5.55K.
  • Revolution Medicines made up ﹤0.01% of Activest Wealth Management's portfolio in Q3 2026, its #651 holding.
  • Activest Wealth Management first reported a position in Revolution Medicines in Q3 2025 and has held it in 3 quarters since.
  • 373 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.